Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT03343600 · TERMINATED

Trial details

NCT number: NCT03343600
Sponsor: National Taiwan University Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Patients Who Have Received Allo-HSCT

Start date: 2017-11-09
Primary completion: 2019-08-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.